Diabetes Technology & Therapeutics

ISSN: 1520-9156• JCR: DIABETES TECHNOL THEMary Ann Liebert, Inc.United States
Visit Journal Homepage
6.3
2025 Impact Factor
5.9
5-Year Impact Factor
Q1
JCR Quartile
B2
CAS Block

Diabetes Technology & Therapeutics impact factor and JCR quartile

The 2025 impact factor for Diabetes Technology & Therapeutics is 6.3. The 5-year impact factor is 5.9. The journal is listed as JCR Q1 in the current Journal Metrics dataset.

Use this record to check the journal title, ISSN, JCR quartile, CAS block, publisher details, and similar journals before comparing publication venues.

If you searched for Diabetes Technology & Therapeutics impact factor 2025, compare this exact title record with the journal homepage and nearby journals in the same field. That helps avoid mixing this journal with a similarly named title, abbreviation, society series, or outdated metric snippet.

2025 impact factor and source check

This page is designed for exact-title searches such as Diabetes Technology & Therapeutics impact factor 2025. First confirm that the ISSN and title match this record before using the metric in a journal shortlist or submission decision.

For high-stakes submission decisions, verify the title against the publisher record at the journal homepage, Clarivate's Master Journal List or Journal Citation Reports if you have access, and the context in our methodology. Treat the 5-year impact factor, JCR quartile, article volume, and similar journals as supporting context rather than a single-number publication decision.

Journal Details

Total Articles
3,869
H-Index
130
Open Access
Hybrid
Subject Areas
Endocrinology, Diabetes and MetabolismSurgeryGeneticsEndocrinology, Diabetes and MetabolismEndocrinology, Diabetes and Metabolism

Article Volume

2021
164
2022
132
2023
149
2024
157
2025
212
2026
92
Back to Search